Uterine Fibroids

Uterine fibroids are benign, monoclonal tumors arising from the smooth muscle cells of the myometrium. They are the most common pelvic tumors in reproductive-aged women, frequently causing abnormal uterine bleeding, pelvic pain, and infertility, though many remain asymptomatic.

Etiology involves a combination of genetic predispositions and hormonal factors. Fibroids are estrogen and progesterone-dependent, as evidenced by their growth during reproductive years and regression after menopause. Genetic mutations, notably in the MED12 gene, are frequently identified.

Pathophysiology involves dysregulated cell proliferation and excessive extracellular matrix (ECM) deposition. Increased concentrations of growth factors (TGF-β, FGF) and estrogen receptors lead to an enlarged, distorted myometrial architecture.

Prevalence is estimated at 70–80% by age

1. Incidence is disproportionately higher and symptoms more severe in women of African descent compared to Caucasian or Asian populations.

Nulliparity, early menarche, African American ethnicity, hypertension, obesity, and family history.

A. Early Symptoms
Pelvic pressure, mild bloating, infrequent spotting. B. Common Symptoms
Menorrhagia (heavy menstrual bleeding), pelvic pain, dysmenorrhea, urinary frequency. C. Advanced Symptoms
Severe anemia from blood loss, chronic pelvic pain, infertility, recurrent pregnancy loss, abdominal distension. D. Emergency Symptoms
Acute, severe pain due to fibroid torsion or degeneration; massive vaginal hemorrhage.

Inspection may reveal abdominal distension. Bimanual pelvic examination typically reveals an enlarged, irregular, firm, and often non-tender uterus.

A. Clinical Assessment: Pelvic exam, history.
B. Laboratory Testing: CBC for anemia.
C. Imaging Studies: Pelvic ultrasound (Transvaginal/Transabdominal).
D. Functional Tests: Not applicable.
E. Biopsy Findings: Usually reserved for suspected malignancy (leiomyosarcoma).
F. Genetic Testing: Not routinely performed.
G. Differential Diagnosis: Adenomyosis, ovarian masses, pregnancy, endometrial cancer.

Complete Blood Count (CBC)
Type: Blood Test
Purpose: Assess for iron-deficiency anemia
Expected Findings: Low hemoglobin/hematocrit
Interpretation: Indicates chronic blood loss requiring iron or surgical intervention.

Transvaginal Ultrasound (TVUS): First-line imaging; identifies location and size.
MRI: Superior for mapping multiple fibroids prior to surgical planning.

Adenomyosis, Ovarian cysts, Endometrial polyps, Uterine malignancy (sarcoma).

Anemia, infertility, pregnancy complications (malpresentation, preterm labor), ureteral obstruction.

A. Lifestyle Modifications: Weight management, exercise.
B. Preventive Measures: None clinically proven.
C. Medical Treatment: GnRH agonists/antagonists (suppress estrogen), COCs (control bleeding), Tranexamic acid (reduce flow).
D. Surgical Treatment: Myomectomy (fertility-sparing), Hysterectomy (definitive).
E. Interventional Procedures: Uterine Artery Embolization (UAE), MRI-guided focused ultrasound.
F. Rehabilitation: Pelvic floor physical therapy.
G. Emergency Management: Stabilization, surgical intervention for torsion/hemorrhage.

Excellent; condition is benign. Symptoms usually resolve after menopause.

No primary prevention; screening is based on clinical presentation.

The following homeopathic remedies have been historically indicated for symptoms associated with Uterine Fibroids. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Uterine Fibroids.